Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

TearLab Corp (TEAR) USD0.001

Sell:$0.06 Buy:$0.06 Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.06
Buy:$0.06
Change: No change
Deal now Deal for just £11.95 per trade in a SIPP or Fund and Share Account
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.06
Buy:$0.06
Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.

Contact details

Address:
9980 Huennekens St Ste 100
SAN DIEGO
92121-2968
United States
Telephone:
+1 (858) 7941400
Website:
www.tearlab.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
TEAR
ISIN:
US8781932004
Market cap:
$731,820
Shares in issue:
12.20 million
Sector:
Health Care Supplies
Exchange:
OTC Bulletin Board
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Elias Vamvakas
    Chairman of the Board
  • Joseph Jensen
    President, Chief Executive Officer, Chief Operating Officer, Director
  • Michael Marquez
    Interim Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.